These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 21641806)
21. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
24. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
25. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo. Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390 [TBL] [Abstract][Full Text] [Related]
26. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381 [TBL] [Abstract][Full Text] [Related]
27. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
28. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
29. The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes. Fasehee H; Zarrinrad G; Tavangar SM; Ghaffari SH; Faghihi S Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():587-95. PubMed ID: 27040254 [TBL] [Abstract][Full Text] [Related]
30. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. Yallapu MM; Gupta BK; Jaggi M; Chauhan SC J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257 [TBL] [Abstract][Full Text] [Related]
31. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508 [TBL] [Abstract][Full Text] [Related]
32. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
34. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Jain S; Rathi VV; Jain AK; Das M; Godugu C Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576 [TBL] [Abstract][Full Text] [Related]
35. Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway. Wang Y; Li J; Chen JJ; Gao X; Huang Z; Shen Q Mol Pharm; 2017 Apr; 14(4):1120-1132. PubMed ID: 28291364 [TBL] [Abstract][Full Text] [Related]
36. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
37. Selectivity of folate conjugated polymer micelles against different tumor cells. Zhao H; Yung LY Int J Pharm; 2008 Feb; 349(1-2):256-68. PubMed ID: 17850996 [TBL] [Abstract][Full Text] [Related]
38. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles. Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749 [TBL] [Abstract][Full Text] [Related]
39. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Zhang Z; Feng SS Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085 [TBL] [Abstract][Full Text] [Related]
40. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Kim SH; Jeong JH; Chun KW; Park TG Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]